Keyword: UCB

Research & Innovation

Artificial Intelligence for New Drug Design

16.09.2021 -

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.


UCB Buys Handl, Partners Lacerta

16.11.2020 -

Belgian biopharma UCB has announced two moves that will boost its gene therapy capabilities.


UCB Acquires Engage Therapeutics

10.06.2020 - Belgian biopharma UCB has acquired US clinical-stage pharmaceutical company Engage Therapeutics. The Summit, New Jersey-headquartered firm is developing Staccato Alprazolam, an...

Strategy & Management

At the Crossroads of Technology and Information

09.11.2016 - With the FDA approving the first 3D printed drug in 2016, emerging technologies are having a significant effect on the pharmaceutical industry. And it’s not just on the patient...

Sites & Services

Raising the Profile of Your Information Center

15.04.2016 - In today's corporate information centers, librarians are faced with endless challenges, from shrinking budgets and limited resources to ever-changing technology and information...

Strategy & Management

The Art of the Alliance

04.04.2016 - Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...


Pharma Majors Join Parkinson’s Initiative

24.02.2016 - Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...


Mallinckrodt Challenge Says FDA Overstepped Bounds

08.06.2015 - An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...